12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga·05/05/2026 12:06:34
Listen to the news
Gainers
- Cellectar Biosciences (NASDAQ:CLRB) stock moved upwards by 45.0% to $4.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $11.9 million.
- Viridian Therapeutics (NASDAQ:VRDN) shares increased by 27.38% to $17.91. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q1 earnings came out today.
- Cytokinetics (NASDAQ:CYTK) shares increased by 26.95% to $83.86. The market value of their outstanding shares is at $8.2 billion. The company's, Q1 earnings came out today.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 24.99% to $3.9. The market value of their outstanding shares is at $10.1 million.
- Edgewise Therapeutics (NASDAQ:EWTX) stock rose 20.82% to $38.0. The market value of their outstanding shares is at $3.3 billion.
- Regentis Biomaterials (AMEX:RGNT) shares increased by 17.64% to $3.0. The company's market cap stands at $13.2 million.
Losers
- GeneDx Holdings (NASDAQ:WGS) stock fell 41.9% to $39.48 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q1 earnings report came out yesterday.
- Embecta (NASDAQ:EMBC) stock decreased by 31.9% to $6.3. The company's market cap stands at $547.7 million. As per the news, the Q2 earnings report came out today.
- Picard Medical (AMEX:PMI) stock decreased by 29.6% to $0.25. The company's market cap stands at $26.5 million.
- CNS Pharmaceuticals (NASDAQ:CNSP) shares decreased by 23.35% to $6.01. The market value of their outstanding shares is at $6.3 million.
- Akanda (NASDAQ:AKAN) stock declined by 22.41% to $31.88. The company's market cap stands at $21.9 million.
- Lunai Bioworks (NASDAQ:LNAI) shares declined by 18.98% to $0.26. The company's market cap stands at $11.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.